Colombia Quickly Becoming a Global Leader in Medical Marijuana

PALM BEACH, Florida, June 20, 2018 /PRNewswire/ --

Marketnewsupdates.com Market Commentary 

With the global community quickly embracing the medical attributes of medical marijuana, most notably in Latin America, coupled with millions of patients worldwide, marijuana companies are quickly gaining international exposure to realize higher valuations. Several legitimate players include Khiron Life Sciences Corporation (OTC:KHRNF) (TSX-V:KHRN), Aphria Inc. (OTC: APHQF) (TSX: APH), MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), Aurora Cannabis (OTC: ACBFF) (TSX: ACB) and Cara Therapeutics (NASDAQ: CARA).

Whether it be Colombian-based Khiron Life Sciences Corporation, which produces cannabis on its 2,000,000 sq. ft. facility near Bogota, Colombia, or Canopy Growth's growth in the U.S., Canada, South America, and Europe related companies are widening global footprints for growth, offering investors a good deal of promise.

Colombia Medical Marijuana Poised for Global Domination 

Colombia, for example, could become one of the largest global export leaders in medical marijuana since legislation in the region passed in 2017, establishing a framework for commercial medical cannabis cultivation.  In fact, Colombia could supply 44% of the global demand for medical cannabis this year, as noted by Andres Lopez, the director of Colombia's National Drug Fund, as quoted by Medical Marijuana Inc.

Helping to foster further growth, Colombia recently approved a law to promote the use of cannabis-based medication.  In fact, according to Marijuana Business Daily, "With a potential count more than double Canada's, Colombia's medical marijuana market is quickly gaining recognition as a legitimate force in the global cannabis industry."

That, coupled with demand in Colombia should fuel even more growth, as more than 2.2 million people suffer with chronic pain.  Another 475,000 suffer with post-traumatic stress disorder (PTSD).  More than 520,000 deal with insomnia.

Companies such as Wheaton Income Corporation could benefit from this after announcing a deal with Colombian federally licensed Inverell, S.A., which gives Wheaton a strong foothold in the international market.

However, it's not just demand that's attracting capital to the region.

Recent new listings on major stock exchanges are doing that, too.  In fact, Khiron Life Sciences just became the first Colombian medical cannabis company on the TSX Venture Exchange.